Treating Spinal Cord Injury With Early Normobaric Hyperoxia

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT07465302
Phase
PHASE2
Status
Recruiting

Conditions

  • Traumatic Spinal Cord Injuries

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Normobaric Hyperoxia — OTHER
    Intermittent normobaric hyperoxia (NBH) by increasing FiO2 to 100% for a duration of 4.5h (270 min), twice daily over five consecutive days. Instead of fixed 12-hour intervals between sessions, the two daily treatments will follow a pre-specified interval: a minimum of 1.5h (90min) between sessions for treatment B, and 10h (600min) for treatment A.

Study Details

SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.

Key Dates

Start date
Apr 15, 2026
Status verified
Feb 2026
Primary completion
Mar 30, 2028
Completion
Sep 30, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Normobaric hyperoxia

Primary Outcome Measure

Feasibility of early normobaric hyperoxic therapy [ Time Frame: 24 hours from injury ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of FloridaGainesvilleFlorida32610
Andrew Kline
724-496-8034

Find similar trials in Gainesville, FL